Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
JensonR+ is a specialized technical consultancy and service provider for the life sciences industry, headquartered in the United Kingdom with additional operations in Ireland. Formed in 2011 as a joint venture with the German regulatory consultancy Regenold GmbH, the company provides comprehensive support across the entire product lifecycle, from early-stage development to post-marketing surveillance. Their core expertise includes regulatory affairs, quality assurance, drug safety (pharmacovigilance), and medical information for human and veterinary medicines, medical devices, and cosmetics. JensonR+ also acts as a marketing authorization holder for generic pharmaceuticals in the European market, such as Ivabradine JensonR. The firm serves a diverse clientele ranging from small biotech startups and entrepreneurs to large multinational pharmaceutical corporations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on JensenR.